• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胸膜间皮瘤(PMe):一种罕见且侵袭性癌症的不断发展的分子知识。

Pleural mesothelioma (PMe): The evolving molecular knowledge of a rare and aggressive cancer.

机构信息

Centre for Clinical Pharmacology and Precision Medicine William Harvey Research Institute, Queen Mary University of London, UK.

Department of Biology, University of Rome Tor Vergata, Rome, Italy.

出版信息

Mol Oncol. 2024 Apr;18(4):797-814. doi: 10.1002/1878-0261.13591. Epub 2024 Mar 8.

DOI:10.1002/1878-0261.13591
PMID:38459714
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10994233/
Abstract

Mesothelioma is a type of late-onset cancer that develops in cells covering the outer surface of organs. Although it can affect the peritoneum, heart, or testicles, it mainly targets the lining of the lungs, making pleural mesothelioma (PMe) the most common and widely studied mesothelioma type. PMe is caused by exposure to fibres of asbestos, which when inhaled leads to inflammation and scarring of the pleura. Despite the ban on asbestos by most Western countries, the incidence of PMe is on the rise, also facilitated by a lack of specific symptomatology and diagnostic methods. Therapeutic options are also limited to mainly palliative care, making this disease untreatable. Here we present an overview of biological aspects underlying PMe by listing genetic and molecular mechanisms behind its onset, aggressive nature, and fast-paced progression. To this end, we report on the role of deubiquitinase BRCA1-associated protein-1 (BAP1), a tumour suppressor gene with a widely acknowledged role in the corrupted signalling and metabolism of PMe. This review aims to enhance our understanding of this devastating malignancy and propel efforts for its investigation.

摘要

间皮瘤是一种迟发性癌症,发生在覆盖器官外表面的细胞中。虽然它可能影响腹膜、心脏或睾丸,但主要针对肺部的衬里,使胸膜间皮瘤(PMe)成为最常见和广泛研究的间皮瘤类型。PMe 是由暴露于石棉纤维引起的,石棉纤维吸入后会导致胸膜炎症和瘢痕形成。尽管大多数西方国家都禁止使用石棉,但 PMe 的发病率仍在上升,这也与缺乏特定的症状和诊断方法有关。治疗选择也仅限于主要的姑息治疗,因此这种疾病无法治愈。在这里,我们通过列出其发病、侵袭性和快速进展背后的遗传和分子机制,概述了 PMe 的生物学方面。为此,我们报告了去泛素化酶 BRCA1 相关蛋白-1(BAP1)的作用,BAP1 是一种肿瘤抑制基因,在 PMe 的受损信号转导和代谢中具有广泛的作用。本综述旨在增强我们对这种毁灭性恶性肿瘤的理解,并推动对其进行研究的努力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b330/10994233/a3c7590177c2/MOL2-18-797-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b330/10994233/ee6dfbcf9b73/MOL2-18-797-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b330/10994233/46678ac65e7a/MOL2-18-797-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b330/10994233/34a0c3e2b652/MOL2-18-797-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b330/10994233/67a946db5b82/MOL2-18-797-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b330/10994233/2f19bbbe994a/MOL2-18-797-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b330/10994233/a3c7590177c2/MOL2-18-797-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b330/10994233/ee6dfbcf9b73/MOL2-18-797-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b330/10994233/46678ac65e7a/MOL2-18-797-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b330/10994233/34a0c3e2b652/MOL2-18-797-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b330/10994233/67a946db5b82/MOL2-18-797-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b330/10994233/2f19bbbe994a/MOL2-18-797-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b330/10994233/a3c7590177c2/MOL2-18-797-g007.jpg

相似文献

1
Pleural mesothelioma (PMe): The evolving molecular knowledge of a rare and aggressive cancer.胸膜间皮瘤(PMe):一种罕见且侵袭性癌症的不断发展的分子知识。
Mol Oncol. 2024 Apr;18(4):797-814. doi: 10.1002/1878-0261.13591. Epub 2024 Mar 8.
2
BAP1 protein is a progression factor in malignant pleural mesothelioma.BAP1 蛋白是恶性胸膜间皮瘤的进展因子。
Pathol Oncol Res. 2014 Jan;20(1):145-51. doi: 10.1007/s12253-013-9677-2. Epub 2013 Aug 22.
3
An asbestos-exposed family with multiple cases of pleural malignant mesothelioma without inheritance of a predisposing BAP1 mutation.一个有石棉接触史的家庭,出现多例胸膜恶性间皮瘤,且无易患性BAP1突变的遗传情况。
Cancer Genet. 2015 Oct;208(10):502-7. doi: 10.1016/j.cancergen.2015.07.004. Epub 2015 Jul 30.
4
The Rocky Road from Preclinical Findings to Successful Targeted Therapy in Pleural Mesothelioma.从临床前发现到胸膜间皮瘤靶向治疗的艰难历程。
Int J Mol Sci. 2022 Nov 3;23(21):13422. doi: 10.3390/ijms232113422.
5
Germline mutations in DNA repair genes predispose asbestos-exposed patients to malignant pleural mesothelioma.胚系 DNA 修复基因突变使石棉暴露患者易患恶性胸膜间皮瘤。
Cancer Lett. 2017 Oct 1;405:38-45. doi: 10.1016/j.canlet.2017.06.028. Epub 2017 Jul 4.
6
Genome-wide analysis of abdominal and pleural malignant mesothelioma with DNA arrays reveals both common and distinct regions of copy number alteration.利用DNA阵列对腹部和胸膜恶性间皮瘤进行全基因组分析,揭示了拷贝数改变的共同区域和不同区域。
Cancer Biol Ther. 2016;17(3):328-35. doi: 10.1080/15384047.2016.1145850. Epub 2016 Feb 6.
7
Metabolic rewiring and redox alterations in malignant pleural mesothelioma.恶性胸膜间皮瘤中的代谢重排和氧化还原改变。
Br J Cancer. 2020 Jan;122(1):52-61. doi: 10.1038/s41416-019-0661-9. Epub 2019 Dec 10.
8
[Research progress on pathogenesis of malignant mesothelioma].[恶性间皮瘤发病机制的研究进展]
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2024 Mar 20;42(3):232-240. doi: 10.3760/cma.j.cn121094-20221226-00604.
9
Association Study of Pleural Mesothelioma and Oncogenic Simian Virus 40 in the Crocidolite-Contaminated Area of Dayao County, Yunnan Province, Southwest China.中国西南云南省大姚县青石棉污染区胸膜间皮瘤与致癌性猿猴 40 型病毒的关联研究。
Genet Test Mol Biomarkers. 2024 May;28(5):189-198. doi: 10.1089/gtmb.2023.0532. Epub 2024 Apr 18.
10
Five years update on relationships between malignant pleural mesothelioma and exposure to asbestos and other elongated mineral particles.恶性胸膜间皮瘤与石棉及其他细长矿物颗粒暴露之间关系的五年更新
J Toxicol Environ Health B Crit Rev. 2016;19(5-6):151-172. doi: 10.1080/10937404.2016.1193361.

引用本文的文献

1
Genetic variability of and response to treatment with cisplatin in combination with pemetrexed or gemcitabine in patients with malignant mesothelioma.恶性间皮瘤患者中顺铂联合培美曲塞或吉西他滨治疗的基因变异性及反应
Radiol Oncol. 2025 Sep 5;59(3):403-411. doi: 10.2478/raon-2025-0049. eCollection 2025 Sep 1.
2
Combining Chemotherapeutic Agents, Targeted Therapies, Vaccines and Natural Bioactive Compounds for Mesothelioma: Advances and Perspectives.联合化疗药物、靶向治疗、疫苗和天然生物活性化合物治疗间皮瘤:进展与展望
Oncol Res. 2025 Aug 28;33(9):2181-2204. doi: 10.32604/or.2025.066708. eCollection 2025.
3

本文引用的文献

1
Cost-effectiveness analysis of nivolumab plus ipilimumab chemotherapy as the first-line treatment for unresectable malignant pleural mesothelioma.纳武利尤单抗联合伊匹木单抗化疗作为不可切除恶性胸膜间皮瘤一线治疗的成本效益分析
Ther Adv Med Oncol. 2022 Aug 3;14:17588359221116604. doi: 10.1177/17588359221116604. eCollection 2022.
2
Cost-effectiveness of nivolumab plus ipilimumab as first-line treatment for American patients with unresectable malignant pleural mesothelioma.尼伏鲁单抗联合伊匹单抗作为不可切除恶性胸膜间皮瘤美国患者一线治疗的成本效益。
Front Public Health. 2022 Jul 22;10:947375. doi: 10.3389/fpubh.2022.947375. eCollection 2022.
3
Inhibition of YB-1 phosphorylation enhances cisplatin activity and disrupts cell division in pleural mesothelioma.
抑制 YB-1 磷酸化可增强顺铂活性并扰乱胸膜间皮瘤中的细胞分裂。
Br J Cancer. 2025 Sep 4. doi: 10.1038/s41416-025-03177-0.
4
Pleural mesothelioma patients and ex-exposed asbestos workers are immunologically poor responders to oncogenic Merkel cell polyomavirus.胸膜间皮瘤患者和曾经接触过石棉的工人对致癌性默克尔细胞多瘤病毒的免疫反应较差。
Transl Lung Cancer Res. 2025 Jul 31;14(7):2611-2625. doi: 10.21037/tlcr-2025-198. Epub 2025 Jul 28.
5
Diagnostic Challenges in the Pathological Approach to Pleural Mesothelioma.胸膜间皮瘤病理诊断方法中的挑战
Cancers (Basel). 2025 Feb 1;17(3):481. doi: 10.3390/cancers17030481.
6
Malignant Mesothelioma: Overcoming Diagnostic Hurdles.恶性间皮瘤:克服诊断难题
Cureus. 2024 Sep 5;16(9):e68718. doi: 10.7759/cureus.68718. eCollection 2024 Sep.
7
[Advances in Targeted Therapy for Malignant Pleural Mesothelioma].[恶性胸膜间皮瘤的靶向治疗进展]
Zhongguo Fei Ai Za Zhi. 2024 May 20;27(5):391-398. doi: 10.3779/j.issn.1009-3419.2024.102.18.
8
Global burden of mesothelioma attributable to occupational asbestos exposure in 204 countries and territories: 1990-2019.全球 204 个国家和地区归因于职业性石棉暴露的间皮瘤全球负担:1990-2019 年。
J Cancer Res Clin Oncol. 2024 May 28;150(5):282. doi: 10.1007/s00432-024-05802-6.
BAP1 Loss by Immunohistochemistry Predicts Improved Survival to First-Line Platinum and Pemetrexed Chemotherapy for Patients With Pleural Mesothelioma: A Validation Study.
免疫组织化学检测 BAP1 缺失可预测恶性胸膜间皮瘤患者一线铂类和培美曲塞化疗的生存获益:一项验证性研究。
J Thorac Oncol. 2022 Jul;17(7):921-930. doi: 10.1016/j.jtho.2022.04.008. Epub 2022 Apr 27.
4
Current treatments for inoperable mesothelioma: indirect comparisons based on individual patient data reconstructed retrospectively from 4 trials.无法手术的间皮瘤的当前治疗方法:基于从4项试验中回顾性重建的个体患者数据进行的间接比较。
J Chemother. 2023 Apr;35(2):158-162. doi: 10.1080/1120009X.2022.2061183. Epub 2022 Apr 12.
5
Comparison of 3 Randomized Clinical Trials of Frontline Therapies for Malignant Pleural Mesothelioma.比较恶性胸膜间皮瘤一线治疗的 3 项随机临床试验。
JAMA Netw Open. 2022 Mar 1;5(3):e221490. doi: 10.1001/jamanetworkopen.2022.1490.
6
A Real-World Analysis of the Use of Systemic Therapy in Malignant Pleural Mesothelioma and the Differential Impacts on Overall Survival by Practice Pattern.恶性胸膜间皮瘤全身治疗应用的真实世界分析及实践模式对总生存期的差异影响
JTO Clin Res Rep. 2022 Jan 12;3(3):100280. doi: 10.1016/j.jtocrr.2022.100280. eCollection 2022 Mar.
7
Distribution of Asbestos Enterprises and Asbestosis Cases - China, 1997-2019.1997 - 2019年中国石棉企业与石棉沉滞症病例分布情况
China CDC Wkly. 2020 May 1;2(18):305-309. doi: 10.46234/ccdcw2020.078.
8
Integrated genomics point to immune vulnerabilities in pleural mesothelioma.整合基因组学揭示胸膜间皮瘤的免疫脆弱性。
Sci Rep. 2021 Sep 27;11(1):19138. doi: 10.1038/s41598-021-98414-w.
9
The pathogenesis of mesothelioma is driven by a dysregulated translatome.间皮瘤的发病机制是由失调的翻译组学驱动的。
Nat Commun. 2021 Aug 13;12(1):4920. doi: 10.1038/s41467-021-25173-7.
10
Assessment of Global Trends in the Diagnosis of Mesothelioma From 1990 to 2017.1990年至2017年间间皮瘤诊断的全球趋势评估。
JAMA Netw Open. 2021 Aug 2;4(8):e2120360. doi: 10.1001/jamanetworkopen.2021.20360.